Comparison between Chandra Bhagat Pharma IPO and RO Jewels IPO.
Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while RO Jewels IPO is a SME Fixed Price proposed to list at BSE SME.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Broking Ltd. | First Overseas Capital Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Beeline Broking Ltd. | Beeline Broking Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the RO Jewels IPO is up to ₹4.67 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of RO Jewels IPO is ₹36.00 per share.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 19,00,000 shares | 12,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.69 Cr | up to ₹4.67 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,00,000 shares | 12,96,000 shares |
| Issue Size Total (Amount) | up to ₹9.69 Cr | up to ₹4.67 Cr |
Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while RO Jewels IPO opens on Mar 12, 2020. The closing date of Chandra Bhagat Pharma IPO and RO Jewels IPO is Feb 06, 2020, and Mar 17, 2020, respectively.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 31, 2020 | Mar 12, 2020 |
| Issue Close | Feb 06, 2020 | Mar 17, 2020 |
| Basis Of Allotment (Tentative) | Feb 11, 2020 | Mar 20, 2020 |
| Initiation of Refunds (Tentative) | Feb 13, 2020 | Mar 23, 2020 |
| Credit of Share (Tentative) | Feb 13, 2020 | Mar 24, 2020 |
| Listing date (Tentative) | Feb 14, 2020 | Mar 25, 2020 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to RO Jewels IPO P/E ratio of 34.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 96.72 | 87.38 | ||||
| Promoter Shareholding (Post-Issue) | 71.08 | 45.26 | ||||
| P/E Ratio | 51 | 34 | ||||
| Market Cap | ₹38.48 Cr. | ₹10.20 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in RO Jewels IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in RO Jewels IPO.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,00,000 shares | 69,000 shares |
| QIB | ||
| NII | 9,50,000 shares | 6,48,000 shares |
| RII | 9,50,000 shares | 6,48,000 shares |
| Employee | ||
| Others | ||
| Total | 19,00,000 shares | 12,96,000 shares |
Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas RO Jewels IPO subscribed 1.19x.
| Chandra Bhagat Pharma IPO | RO Jewels IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.87x | 1.95x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.44x | 0.43x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.65x | 1.19x |
